Borzumati M, Vio P, Bonvegna F, Funaro L, Baroni A
Struttura Complessa Nefrologia e Dialisi, Verbania, Italy.
G Ital Nefrol. 2009 May-Jun;26(3):369-71.
In uremic patients on hemodialysis, a first vascular access using native vessels tailored into a radiocephalic arteriovenous fistula (AVF) on the wrist is the gold standard in vascular access quality. However, among the uremic population the percentage of older patients affected by diabetes or by severe generalized vascular disease is growing. In these patients distal radiocephalic AVFs often have a limited survival. This induced us to design a technique for tailoring vascular accesses at a proximal site. In the past two years (2006-2007) we created 19 AVFs at the midarm position (midarm AVF) using the proximal section of the radial artery. Midarm AVF was the second choice in 70% of patients after failure of a distal AVF and the first choice in 30% of patients. The survival of this type of access has been excellent. We have registered only one thrombosis after 6 months. In four cases access was interrupted because of the death of the patients. The remaining 14 accesses are working perfectly well. Our experience leads us to conclude that midarm AVF is not only an important intermediate step after the failure of a distal AVF and before the application of a proximal AVF, but in a population of patients with diabetes and generalized vascular disease it should probably be proposed as the AVF of choice.
在接受血液透析的尿毒症患者中,利用手腕部的自体血管构建桡动脉头静脉内瘘(AVF)作为首次血管通路是血管通路质量的金标准。然而,在尿毒症患者群体中,受糖尿病或严重全身性血管疾病影响的老年患者比例正在增加。在这些患者中,远端桡动脉头静脉内瘘的使用寿命往往有限。这促使我们设计一种在近端部位构建血管通路的技术。在过去两年(2006 - 2007年),我们利用桡动脉近端在手臂中部位置创建了19个AVF(上臂中部AVF)。在70%的患者中,上臂中部AVF是远端AVF失败后的第二选择,在30%的患者中是第一选择。这种类型的血管通路使用寿命极佳。我们仅记录到1例在6个月后发生血栓形成。有4例因患者死亡导致血管通路中断。其余14个血管通路运行良好。我们的经验使我们得出结论,上臂中部AVF不仅是远端AVF失败后和近端AVF应用前的重要中间步骤,而且在患有糖尿病和全身性血管疾病的患者群体中,它可能应被推荐为首选的AVF。